RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RAD51 and Breast Cancer Susceptibility: No Evidence for Rare Variant Association in the Breast Cancer Family Registry Study
Authors
Keywords
Sequence alignment, Breast cancer, Multiple alignment calculation, Genetic causes of cancer, Cancer screening, DNA recombination, Genetic screens, Mutation
Journal
PLoS One
Volume 7, Issue 12, Pages e52374
Publisher
Public Library of Science (PLoS)
Online
2012-12-28
DOI
10.1371/journal.pone.0052374
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rare Mutations in XRCC2 Increase the Risk of Breast Cancer
- (2012) D.J. Park et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Is RAD51 135G>C polymorphism really associated with breast cancer in general population? Biased design and results lead to inappropriate conclusion
- (2011) Ke-Da Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- Germline mutations in RAD51D confer susceptibility to ovarian cancer
- (2011) Chey Loveday et al. NATURE GENETICS
- RAD51 G135C polymorphism is associated with breast cancer susceptibility: a meta-analysis involving 22,399 subjects
- (2010) Haiming Sun et al. BREAST CANCER RESEARCH AND TREATMENT
- Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer
- (2010) Yonglan Zheng et al. BREAST CANCER RESEARCH AND TREATMENT
- RAD51 135G>C polymorphism contributes to breast cancer susceptibility: a meta-analysis involving 26,444 subjects
- (2010) Zhanwei Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- RAD51 135G>C does not modify breast cancer risk in non-BRCA1/2 mutation carriers: evidence from a meta-analysis of 12 studies
- (2010) Ke-Da Yu et al. BREAST CANCER RESEARCH AND TREATMENT
- RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies
- (2010) Lin-Bo Gao et al. BREAST CANCER RESEARCH AND TREATMENT
- Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene
- (2010) Alfons Meindl et al. NATURE GENETICS
- A method and server for predicting damaging missense mutations
- (2010) Ivan A Adzhubei et al. NATURE METHODS
- Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2
- (2010) Eloïse Dray et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Rare, Evolutionarily Unlikely Missense Substitutions in ATM Confer Increased Risk of Breast Cancer
- (2009) Sean V. Tavtigian et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Determining the effectiveness of High Resolution Melting analysis for SNP genotyping and mutation scanning at the TP53 locus
- (2009) Sonia Garritano et al. BMC GENETICS
- Description and validation of high-throughput simultaneous genotyping and mutation scanning by high-resolution melting curve analysis
- (2009) Tú Nguyen-Dumont et al. HUMAN MUTATION
- Penetrance Analysis of the PALB2 c.1592delT Founder Mutation
- (2008) H. Erkko et al. CLINICAL CANCER RESEARCH
- In silico analysis of missense substitutions using sequence-alignment based methods
- (2008) Sean V. Tavtigian et al. HUMAN MUTATION
- Identification of a novel human Rad51 variant that promotes DNA strand exchange
- (2008) J.-Y. Park et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search